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Abstract 
The API triethylenetetramine dihydrochloride used as an alternative treatment of Wilson’s 
disease is sensitive to water and it exhibits polymorphism. As this may become an issue for the drug 
formulation, the physical stability has been studied by differential scanning calorimetry, high-
pressure thermal analysis, dynamic vapor sorption, and X-ray diffraction as a function of 
temperature. In addition, high-pressure liquid chromatography and mass spectrometry have been 
used to study the purity and chemical stability of the API. A pressure-temperature phase diagram of 
the pure compound has been constructed and it can be concluded that form II is monotropic in 
relation to form I, which is the only stable solid. The solubilities of the different solid forms have been 
determined with the help of a temperature – composition phase diagram. The API is very soluble, at 
20° C about 10 % of the saturated solution with respect to the dihydrate consists of API and the 
solubility of the pure form I is twice as high. Moreover, it has been shown that at 20 °C, a relative 
humidity above 40 % induces the formation of the dihydrate and at 70 % a saturated solution 
appears. At higher temperatures, the formation of the dihydrate appears at lower relative humidity 
values. A clear link has been established between the API’s chemical stability, its physical stability and 
the relative humidity in the air. Humidity levels above 40 % are detrimental to the quality of the API. 
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1 Introduction 
The dihydrochloride salt of triethylenetetramine, 1,2-ethanediamine,N,N’-bis(2-aminoethyl) is a 
polyamine chelator of copper (II) (Figure 1). It is currently used as an alternative to D-penicillamine to 
treat Wilson’s disease.1 Moreover, due to its activity on copper homeostasis triethylenetetramine 
dihydrochloride (TETA⋅2HCl) is being tested for numerous applications such as treatments for 
internal organ damage in diabetes patients,2 Alzheimer’s disease,3 and even cancer.4  
 
Figure 1 Chemical structure of triethylenetetramine dihydrochloride (bottom) and the TETA-Cu complex (top) 
Understanding of the physicochemical stability of TETA⋅2HCl is important for its drug 
development. First, the crystal form such as polymorphism and solvatomorphism may alter physical 
properties such as solubility and chemical reactivity.5 Second, information on decomposition 
products and synthesis impurities is important, because their presence in the bulk drug may impact 
crystal growth kinetics,6, 7 size distribution, and morphology.8 Moreover, impurities may exhibit their 
own biological activities and thus should be controlled in accordance with the regulatory thresholds.9 
Formulations with TETA⋅2HCl have been studied by Fujito et al. and they have shown that this 
active pharmaceutical ingredient (API) is sensitive to moisture.10 The existence of polymorphs has 
been reported,11 which has recently been confirmed by the publication of two crystal structures 
(Table 1).12 In addition, a dihydrate of TETA⋅2HCl has been described in the literature and its structure 
has been solved (Table 1).12, 13 The volumes of the three structures have been reported as a function 
of temperature.12  
The melting point of TETA·2HCl has been reported in the form of a melting range between 115 
and 118 °C in the literature, but it has not been related to the existing polymorphs.14 However, a 
patent discussing the synthesis of several salts of TETA describes both form I and form II and provides 
two DSC curves with melting temperatures 121.96 °C (395.11 K) and 116.16 °C (389.31 K) and melting 
enthalpies of 234.54 J g-1 (51.401 kJ mol-1) and 203.64 J g-1 (44.630 kJ mol-1) for forms I and II, 
respectively.15 Form I, with the higher melting point, can therefore be considered the stable form just 
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below the melting points, however, it is not known which of the two observed polymorphs is stable 
at room temperature and under which conditions the dihydrate may form. 
Table 1. Crystallographic information on the known crystal structures of TETA·2HCl 
Form M (g mol-1) Space group Volume (Å3) Z Ref 
I 219.16 Monoclinic P21/n 572.63(3) 2 12 
II 219.16 Monoclinic P21/c 1167.95(12) 4 12 
Dihydrate 255.20 Monoclinic P21 655.2(2) 4 13 
 
Concerning the chemical stability, many analytical detection techniques have been applied to 
investigate TETA⋅2HCl, including conductivimetry,16 fluorimetry,17 and more recently mass 
spectrometry coupled to HPLC.18 However, these techniques were used to analyze TETA assays in 
biological fluids and to our knowledge no characterization of the impurities due to degradation has 
been published yet. Thus, despite the presence of a reasonable body of work on the pharmaceutical 
implications of TETA and the presence of structural data, very little is known about the chemical and 
physical stability of TETA⋅2HCl. 
In this paper the chemical and physical stability of TETA⋅2HCl in the solid state and its solubility 
will be discussed based on new experimental results on chemical decomposition and phase transition 
data and on crystallographic information from the literature.12, 13, 15 
2 Materials and Methods 
2.1 Materials 
TETA⋅2HCl (standard substance 99.4%, 219.16 g mol-1), analytical grade heptafluorobutyric acid 
(HFBA for mobile phase preparation), and high-performance-liquid-chromatography (HPLC) grade 
acetonitrile (ACN) were purchased from Sigma-Aldrich (Steinheim, Germany). Ultrapure water was 
obtained by deionization and filtration through a Milli-Q water purification system (Millipore, St-
Quentin-en-Yvelines, France). TETA⋅2HCl was used as obtained without further purification. 
Independent stock solutions of 100 µg ml-1 TETA⋅2HCl were prepared by dissolving the appropriate 
amounts of the substance in ultrapure water. 
2.2 Equipment  
2.2.1 Differential scanning calorimetry and thermogravimetry 
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Differential scanning calorimetry (DSC) experiments were carried out with a PYRIS Diamond DSC 
thermal analyzer from Perkin Elmer (Waltham, United States). Indium (Tfus= 429.75 K, ∆fusH=28.45 J.g
-
1) was used as a standard for temperature and enthalpy calibration and samples of approximately 5 
mg were analyzed in pierced aluminum pans at various heating rates (from 1 K min-1 to 20 K min-1) 
under nitrogen atmosphere. Samples were weighed in aluminum pans using a microbalance sensitive 
to 0.01 mg. Pure API samples have been studied as well as mixtures of API with water. 
Thermogravimetric analysis of pure API samples was carried out using a SDT Q600 system (TA 
instruments, New Castle, United States). 
2.2.2 High pressure differential thermal analysis 
The transitions observed by DSC have been studied with high-pressure differential thermal 
analysis (HP-DTA) too. An in-house constructed HP-DTA, similar to the apparatus previously built by 
Würflinger19 with temperature and pressure ranges from 203 to 473 K and 0 to 300 MPa, 
respectively, was used. Samples were sealed in cylindrical tin pans and to ensure that in-pan volumes 
were free from residual air, specimens were mixed with an inert perfluorinated liquid (Galden® from 
Bioblock Scientifics, Illkirch, France) before sealing. HP-DTA scans were carried out with a heating 
rate of 2 K min-1. In addition, DSC runs at ordinary pressure (i.e., in standard aluminum pans) with 
mixtures of TETA⋅2HCl and perfluorinated liquid were carried out to verify that the latter was inert. 
2.2.3 Dynamic Vapor Sorption 
Dynamic Vapor Sorption (DVS) was carried out with a DVS-1000 from Surface Measurement 
Systems (Alperton, United Kingdom). About 10 mg of TETA⋅2HCl has been used in each experiment 
and the relative humidity was slowly varied in the range from 0 to 90 %. The sample was considered 
stable with respect to the imposed water vapor once the fluctuation of its mass was below 0.0001 
m%/min.  
2.2.4 Liquid-Chromatography-Mass spectrometry 
Reversed-phase liquid chromatography (LC) coupled with Mass Spectrometry (MS) detection has 
been used to obtain the impurity profiles of TETA⋅2HCl. 
The LC system (Dionex Corporation, Sunnyvale, United states) consisted of an Ultimate 3000 
quaternary pump and an AS-3000 auto sampler. The column was a Waters Polaris C18 (Waters, 
Milford, United States) with 100 mm length, 2.1 mm internal diameter, and 5 µm particle size. The 
flow rate was set at 0.2 mL min-1 and the sample injection volume was 20 µL. 
A mobile phase gradient was set up (solvent A: HFBA in ultrapure water 0.1% (v/v), solvent B: 
HFBA in ACN 0.1 % (v/v)) to ensure absence of impurity co-elution. Table 2 describes the gradient 
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distribution during the analysis. Inter-run stabilization was set to 5 minutes. The measurement time 
was long enough to ensure observation of late eluting impurities. 
Mass spectrometry detection consisted of an LCQ 3200-QTRAP quadrupole ion trap mass 
spectrometer (ABSciex, Framingham, United States) and an electrospray ionization (ESI) source. The 
ESI source operated in positive ionization mode, with a 5.5 kV spray voltage. The sheath/auxiliary gas 
was highly pure nitrogen (flow rate: 10 psig). Capillary voltage was set to 9.0 V and the capillary 
temperature was 225°C. A range from 50 to 800 mass-to-charge ratio was scanned in the detector. 
LC-MS conditions were optimized in order to ensure detection of the main impurities. A 0.05 % 
threshold was chosen in accordance with ICH recommendations20 and final concentrations of the 
samples were at least 50 µg mL-1 in ultrapure water considering the detection limit of the method. 
Analyst® (ABSciex) was used as data acquisition software. Processing of the MS data was carried out 
with MS Manager® software version 12 (ACD Labs, Toronto, Canada). Theoretical fragmentation 
patterns were computed using MS Fragmentor® software version 12 (ACD Labs, Toronto, Canada). 
Table 2. Mobile phase gradient for the HPLC experiments 
Time after injection (min) Solvent A (% v/v) Solvent B (% v/v) 
0 85 15 
15 70 30 
20 70 30 
21 85 15 
25 85 15 
2.3 Physical stability measurements 
The effect of temperature on TETA⋅2HCl was investigated using the SDT and DSC apparatuses. 
The glass transition and polymorphism were studied by quenching molten samples. The effect of 
water vapor on solid TETA⋅2HCl was assessed by static and dynamic moisture exposure, using 
saturated salt solutions and the DVS apparatus. In addition, TETA⋅2HCl-water mixtures have been 
studied by DSC. 
2.4 Chemical stability in solid state – accelerated stability studies 
For the chemical stability study in the solid state, bulk powder samples of approximately 1 g were 
exposed to three sets of stress conditions. 
(A) exposure to ambient humidity (i.e uncontrolled) at 20 °C ±2 °C aimed to simulate a realistic 
usage condition (monitoring revealed a humidity ranging between 30 and 40 % RH (heated building 
in winter)). 
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(B) exposure to a relative humidity of 43 % RH at room temperature 20 °C ±2 °C. 
(C) exposure to a relative humidity of 75 % RH at a temperature of 40 °C ± 1°C (accelerated stress 
test). 
Samples were conditioned in 1 mL brown glass vials. Chemical purity was assessed at days 0, 7, 
26, 35, and 42. A sample was considered expired by degradation once its TETA content was less than 
90% (%m/m) of a native sample of TETA⋅2HCl. 
3 Results and Discussion 
3.1 Chemical purity of the commercial product  
The chemical purity of triethylenetetramine dihydrochloride was determined by HPLC-MS. The 
experimental daughter-ion mass spectrum of TETA⋅H+ (25 % collision-induced dissociation) and the 
proposed fragmentation pathway are presented in Figure 2. The pathway is a succession of single 
and multiple cleavages of C-N bonds. 
By HPLC, the overall purity of the sample was found to be 99.5 % m/m. One impurity was present 
in the commercial sample as can be seen in the chromatogram in the supplementary information 
(Figure S1). As this impurity was detected in the original material stored under recommended 
conditions (tightly closed container at room temperature and protected from light), it is most likely 
due to the synthesis (peak labeled SI1 in Figure S1). MS/MS analysis of the SI1 elution peak results in 
an m/z of 104 and it leads to a similar fragmentation as observed for TETA⋅H+ (TETA⋅H+ (m/z 147): 70, 
87, 104, 113, and 130 and for SI1 (m/z 104): 70 and 87), indicating that SI1 is closely related; therefore 
it is most likely diethylenetriamine, which is a known impurity of TETA. 
 
a       b 
Figure 2 (a) MS2 scan of TETA (25 % Collision-induced dissociation) (b) proposed fragmentation pathway for TETA. 
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3.2 Stress tests 
TETA⋅2HCl has been subjected to different temperatures and humidities (see section 2.4). In 
particular for conditions B and C, a marked decrease of the amount of TETA is observed with time 
(Figure 3). At 40 °C and 75% RH (condition C), the SI1 impurity increased and two new impurities 
appeared: DI1 with m/z 137 and DI2 with m/z 126 (Shown in Figure S1 in the Supporting Information). 
It demonstrates that TETA⋅2HCl is sensitive to humidity and increased temperature in accordance 
with previous findings by Fujito et al.10  
 
 
Figure 3. Evolution of the quantity of TETA (% m/m0
 obtained by HPLC-MS) in samples under elevated temperature and/or 
humidity (solid diamonds: ambient conditions (20°C, uncontrolled humidity); solid squares: 20°C, 43% RH; solid circles: 
40°C, 75% RH, dashed line: lower acceptance limit) 
3.3 Thermal behavior under ordinary conditions 
Ordinary conditions are defined in this paper as a system in equilibrium with its vapor phase. It 
implies that melting transitions but also solid-solid transitions are observed in equilibrium with their 
partial vapor pressure. Thus, the obtained transition temperatures are triple point temperatures. It 
can be assumed that in the small volume of a DSC capsule the partial pressure of a chemical 
compound will be quickly in equilibrium with its condensed phase. Thus standard DSC measurements 
provide in general data under ordinary conditions. 
The melting point of TETA⋅2HCl was found at 394.6 ± 1 K (121.5 °C) with a melting enthalpy of 
242 ± 9 J g-1 (53.0 ± 1.9 kJ mol-1). Cooling the melted sample down to 213 K with 10 K min-1 and 
reheating gave rise to a glass transition at 256.2 ± 1 K (-16.9 °C, midpoint) on heating (Figure 4). 
Subsequently an exothermic peak was observed linked to recrystallization, which occurred generally 
between 300 K and 360 K. After recrystallization a melting peak was observed at 387.1 ± 1 K (114.0 
°C, Figure 4). The enthalpy associated with this melting transition is 200 ± 11 J g-1 (43.9 ± 2.4 kJ mol-1). 
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Melting peaks in a sealed capsule often had a liquidus like appearance that improved by piercing 
the pan. Generally, no significant weight loss was observed after the DSC measurements with pierced 
pans. Even though other causes cannot be excluded, it may be due to a small amount of adsorbed 
water as the compound is fairly hygroscopic and easily forms a hydrate as will be presented below. In 
TGA measurements and in infrared measurements the presence of small quantities of water was 
often observed. Degradation of the sample during the melt has been excluded, because the HPLC 
profiles of the melted samples were virtually the same from those of the commercial sample. 
However, the melting point and melting enthalpy appeared to decrease slightly after the compound 
had been stored for several months under the recommended conditions (see 3.1 above), with a clear 
effect on recrystallization into form II, in particular visible in its melting enthalpy, which may drop to 
160 J g-1 for samples that have been stored for a long time. Although not confirmed, this may be due 
to slow or incomplete crystallization of the sample because oxidized functional groups prevent or 
slow down recrystallization.  
 
Figure 4. DSC curve (10 K min-1) of the commercial form (form I): heating – cooling (not shown) – heating. First heating leads 
to fusion of form I (TI-L). Reheating the undercooled liquid gives rise to a glass transition (Tg), recrystallization (TL-II) and 
fusion of a different solid phase (form II, TII-L)). 
3.4 The pressure-temperature phase diagram 
The fusion of TETA·2HCl has been studied as a function of pressure and temperature and the 
results are provided in Figure 5. Both solid – liquid equilibria of form I and form II can be described by 
a linear equation in the studied pressure and temperature range. The pressure P (in MPa) as a 
function of the temperature T (in K) is given by the following two expressions obtained by linear 
regression: 
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Form I – L: P = −5612(292) + 14.2(0.7) T 
Eq. 1 
Form II – L: P = −6489(338) + 16.8(0.9) T  
Eq. 2 
Using the equilibrium of the highest melting form, useful information can be obtained on the 
properties of the liquid state. The slope (dP/dT) of a phase equilibrium and thus of Eq. 1 is related to 
the transition enthalpy (ΔH) and the volume change (ΔV) on melting as demonstrated by the 
Clapeyron equation: 
  
Eq. 3 
ΔS is the transition entropy change and T is the temperature at which the enthalpy change has been 
determined. With the Clapeyron equation, the specific volume of the liquid can be calculated on 
melting. 
 
Figure 5 High-Pressure differential thermal analysis data of the fusion of TETA·2HCl with straight lines obtained by linear 
regression, open circles (dashed line): fusion of form II, solid circles (solid line): fusion of form I. 
The volumes of the three known crystal structures with TETA·2HCl have been reported previously 
as a function of the temperature.12 Using Z, which can be found in Table 1, the unit-cell volumes 
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reported in the literature can be expressed in the form of specific volumes (cm3g-1) of the crystals as 
a function of the temperature (K): 
  
form I:   vI,spec = 0.7750(2) + 4.73(8)×10−5 T    
Eq. 4 
form II:   vII,spec = 0.775(3) + 1.06(9) ×10−4 T    
Eq. 5 
dihydrate:   v2H2O,spec = 0.7548(3) + 7.94(12) ×10−5 T   
Eq. 6 
This information will be used here to obtain an estimate of the density of the liquid state. 
Using the slope of Eq. 1, dP/dT = 14.2 MPa K-1, the melting temperature of form I, T = TI-L = 394.6 
K, and the enthalpy of fusion ΔI-LH = 242 J g-1, the specific volume change on melting becomes ΔI-Lv = 
0.0431 ±0.0038 cm3g-1 with Eq. 3. Because the volume of form I is known at its melting point through 
Eq. 4, vI,spec = 0.7937 cm3g-1, the specific volume of the liquid at the melting temperature can be 
calculated and is found to be vL,spec (394.6K) = 0.8367 cm3g-1. The increase in volume on melting is 5.4 
% (or max 5.9 %), which is rather low considering that most small molecules exhibit a volume 
increase on melting of about 11%.21-24 
The maximum thermal expansion of the liquid can be found by linear interpolation between the 
specific volume of the liquid at the melting point of form I and the specific volume of form II at the 
glass transition temperature, Tg = 254 K and vII,spec = 0.8019 cm3g-1, as the glass phase cannot have a 
specific volume lower than this crystalline phase. It leads to a slope of liquid volume versus 
temperature of 2.5×10-4 cm3g-1K-1 and it results in the following expression for the thermal expansion 
of the liquid: vL = 0.7390 + 2.5×10-4 T with vL(T=0) = 0.7390 cm3g-1. The expansion can be compared 
with that of other molecular pharmaceuticals by using the thermal expansion coefficient αvL = 
(dv/dT)/vL(T=0) = 3.4×10-4 K-1. Data on liquids of small molecular pharmaceuticals tend to an average 
αvL of about 1.2×10
-3 K-1;23, 24 the maximum thermal expansion of liquid TETA⋅2HCl is less than a third 
of the average value. A similar trend can be seen for the solids. From Eq. 4 and Eq. 5 it can be derived 
that αvI = 6.1 ×10
-5 K-1 and αvII = 1.4 ×10
-4 K-1 (and for the dihydrate 1.1 ×10-4 K-1). This compares 
against an average value of the solid thermal expansion coefficient for pharmaceuticals of 2.1×10-4 K-
1; thus the thermal expansion of TETA⋅2HCl is overall small. 
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The two-phase equilibria in Figure 5 involve each the melting of a different solid form and 
therefore they cannot be both stable. Because fusion is an order – disorder transition there is no 
significant kinetic barrier and the actual measured melting temperature is the equilibrium 
temperature between the solid and the liquid. Form I melts at a higher temperature than form II and 
must be the more stable solid form in the temperature interval between the two melting equilibria 
and possibly below. According to the rules by Burger and Ramberger,25 the system must be 
monotropic as the higher melting form I has the higher melting enthalpy. Although it may be correct 
for this system, the “heat of transition rule” and “heat of fusion rule” are only based on the 
temperature dimension and they do not take into account the effect of pressure. It is well known 
that melting equilibria under pressure may cross each other and that monotropic systems can 
become enantiotropic under pressure or vice versa.26, 27 To determine whether a stable domain for 
form II exists in the pressure-temperature plane, a P-T phase diagram can be constructed using 
topological arguments, which are purely based on thermodynamics and not on rules that may 
possess exceptions. The strength of the topological method is that it is often overdetermined, which 
allows to verify consistency or when certain data is lacking, such as the density of the melt, which is 
often difficult to measure, it can be calculated through the topological approach. 
 It can be seen that the slope of the II – L equilibrium is steeper than the one for I – L. In addition, 
the ordinate at T = 0 K is lower for the II – L equilibrium. This indicates that the two equilibria diverge 
with increasing pressure and that they intersect at negative pressure. Setting expressions Eq. 1 and 
Eq. 2 equal to each other satisfying the condition of equal pressure at the intersection of the two 
equilibria, one finds a I-II-L triple point temperature of 345 K and a pressure of -710 MPa. Because 
forms I and II are in equilibrium with each other at this triple point, the I-II equilibrium line must cross 
through this point too. 
The slope of the I-II equilibrium can be found using the Clapeyron equation (Eq. 3), once the 
enthalpy change and the volume change for the I-II transition have been determined. At the I-II-L 
triple point temperature of 345 K the specific volumes are vI = 0.7913 cm3g-1 and vII = 0.8115 cm3g-1 
leading to ΔIIIv = 0.0202 cm
3g-1; hence an increase in pressure will stabilize form I, which has the 
smallest specific volume (Le Chatelier). The entropy difference between the two forms can be 
obtained from the melting enthalpies: ΔIIIS = ΔILH/TIL - ΔIILH/TIIL = 0.0949 JK
-1g-1 (taking rounding 
into account). The positive value indicates according to the Le Chatelier principle that an increase in 
temperature will favor the formation of form II. Using the two inequalities an average slope of 4.7 
MPa K-1 is found for the I-II equilibrium, which is less steep than the two melting equilibria (Eq. 1 and 
Eq. 2). It implies that the I-II equilibrium only exists in domains where either the vapor phase or the 
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liquid are stable and that hence the I-II equilibrium has no stable pressure-temperature interval 
(Figure 6). Extrapolating the I-II equilibrium line to 0 MPa, which is approximately the pressure of the 
system under atmospheric conditions, one finds a transition temperature of 496 K (By 
approximation, this temperature in combination with a pressure of 0 MPa can be considered the 
triple point I-II-V (Figure 6a)) The I-II transition temperature can be compared to the alternative value 
of 436 K, obtained with an equation based on the melting temperatures and melting enthalpies of 
the two forms and neglecting the heat capacities.24, 28 Both transition temperatures here obtained, 
496 K and 436 K, should be considered estimates. 
If the latter temperature is used for the coordinates of the triple point I-II-V (436 K, 0 MPa) in 
combination with the I-II-L triple point coordinates of 345 K, -710 MPa, the I-II equilibrium would 
have the slope 7.8 MPa K-1. This slope is twice as large as the one found by Clapeyron, but it is still 
considerably smaller than the slopes of the melting equilibria. Thus the I-II equilibrium has no stable 
domain in the entire pressure-temperature phase diagram. It implies that form I is the only stable 
form because TETA⋅2HCl will always melt before it reaches its I-II equilibrium (Figure 6a). Form II has 
thus an overall monotropic phase relationship with form I and the stable phases of the known 
pressure-temperature phase diagram are form I, the liquid and the vapor (Figure 6b). Systems with 
similar overall monotropic phase behavior are biclotymol,29 rimonabant,30 FK664,24 and more 
recently rotigotine, for which its unexpected monotropy caused a temporary withdrawal from the 
market.31 
a b  
Figure 6. The pressure-temperature phase diagram of pure TETA⋅2HCl (a) containing all known phases and phase 
transitions. Domains: I: stable form I, L: stable liquid, V: stable vapor phase, phase equilibria: black solid lines: stable, grey 
dashed lines: metastable, black dotted lines: supermetastable, triple points: solid black circle: stable, grey circle: 
metastable. (b) phase diagram containing only the stable domains, phase equilibria and triple point. The axes are not to 
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scale; in particular the pressure axis is expanded at low pressures to demonstrate the stability domains of the condensed 
phases in relation to the vapor phase. The stable triple point I-L-V is located at T = 394.6 ± 1 K. 
3.5 The effect of humidity on the stability of TETA⋅2HCl  
To study the phase relationship between pure TETA⋅2HCl and its dihydrate, DVS measurements 
have been carried out at 20, 35, and 45 °C. It can be seen in Figure 7 that at 20°C up to 40 % RH the 
water content in the TETA⋅2HCl sample increases gradually, indicative of water adsorption on the 
surface. At 40% RH the water content of the sample jumps to 67 %, where the mass remains level 
indicating that a dihydrate has formed. It can be seen that the higher the temperature, the lower the 
necessary relative humidity (RH%) to form the dihydrate. In terms of the partial water vapor 
pressure, however, it has to be realized that the water vapor quantity that can be dissolved in air is 
higher at higher temperatures; thus, on an absolute scale a higher partial pressure is needed at 
increased temperatures to form the dihydrate. In other words, the dihydrate is less stable at higher 
temperatures as it becomes more prone to evaporation of its water content. 
 
a        b 
Figure 7. DVS data of TETA·2HCl at 20°C (solid line), 35°C broken line, and 45°C (dotted line) expressed as the mole fraction 
of water in the sample as a function of relative humidity (left-hand side) and as a function of partial water vapor pressure in 
air (right-hand side). The latter is obtained by multiplying the relative humidity fraction with the saturating vapor pressure 
of water for the given temperatures. Both the responses of the system to water vapor increase and to water vapor 
decrease are shown. On increasing the humidity, a stepwise increase in water content is observed: domain ‘a’ is water 
adsorption to TETA·2HCl, ‘b’ formation of dihydrate, ‘c’ water adsorption to the dihydrate, ‘d’ dissolution of the dihydrate, 
and ‘e’ dilution of the solution. On decreasing the humidity, ‘f’ the solution becomes ever more concentrated. In none of 
the curves shown here, the weight comes back to zero, but this will eventually happen, if the compound is exposed to 0 % 
humidity for a long enough time (see also Figure S2 in the Supporting Information). For more information on the 
interpretation of DVS measurements, one can refer to the case of citric acid and its hydrate.32 
The DVS data provide TETA – water concentrations in equilibrium with the water vapor pressure. 
Thus the partial vapor pressure and the concentration for specific events can be extracted from the 
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measurements as a function of temperature. In the first place the equilibrium pressure of the 
formation of the dihydrate can be obtained, because it is equal to the pressure at which the sudden 
water increase levels off (intersection of domains b and c in Figure 7a). The equilibrium pressure of 
the dihydrate versus temperature can be found in Table 3. After the dihydrate has formed (domain c 
in Figure 7a), the weight of the sample slowly increases, after which dissolution takes place (domain 
d). This process stops once the entire dihydrate has dissolved and from then on an increasing vapor 
pressure dilutes the saturated solution (domain e). Thus, at the intersection of the dissolution and 
dilution curves (d and e), the concentration and partial water vapor pressure of the saturated 
solution can be found. The values have been reported in Table 3. A similar graph as in Figure 7a, but 
only for the formation of the dihydrate and the hysteresis (persistence of the dihydrate) on reducing 
the relative humidity can be found in the Supporting Information Figure S2. 
Table 3. Partial water vapor pressures (Pwater) at the completion of the formation of the dihydrate and at the point of 
saturation for TETA⋅2HCl together with the concentration of the saturated solution as a function of the temperature (T) 
T (°C) 20 35 45 
 Hydrate formation 
Pwater (Pa) 1051 2531 3834 
 Saturated solution 
Pwater (Pa) 1645 3406 4706 
Mole fraction TETA⋅2HCl 0.10 0.12 0.16  
The Pwater values in Table 3 have been plotted as a function of the temperature T in Figure 8. How 
the expressions for the lines have been obtained will be explained below in a later section. At this 
point, the graph in Figure 8 demonstrates which of the phases, solid TETA⋅2HCl, the dihydrate 
TETA⋅2HCl⋅2H2O (narrow area between the dashed line and the solid line), and the solution (= a 
solution of TETA⋅2HCl in water), is stable depending on the partial water vapor pressure and on the 
temperature. It is clear that there is always water vapor in the presence of the condensed phases 
(except for pure TETA⋅2HCl in a sealed container, which is represented by the x-axis). 
Considering the experimental conditions for the chemical stability studies discussed above, 
condition A with about 30 % RH at 20° C can now be located in domain a in Figure 7a or below the 
solid line in Figure 8. This confirms the stability of the sample from a physical and chemical point of 
view; TETA⋅2HCl (s) is the stable form under these conditions, which gives water little chance to 
affect it chemically. When at 20°C, the relative humidity is increased to 43 %, TETA⋅2HCl degrades 
steadily. From Figure 7, it can be seen that under these conditions the dihydrate is the stable form 
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and water will therefore be present throughout the crystal. This clearly increases the chemical 
degradation of the API. Increasing the relative humidity to 75 % and 40° C brings the sample into the 
region where it will liquefy as can be judged from Figure 7. In Figure 8 it will have passed (at 313 K) 
above the dashed line. Clearly, being in solution increases the chances of degradation of the API 
considerably. 
 
Figure 8. Vapor pressure equilibria as a function of the partial water vapor pressure and the temperature. Solid diamonds: 
measurement points of the formation of the dihydrate, solid circles: measurement points of the formation of the saturated 
solution (see Table 3), solid line: fit to the dihydrate formation data (Eq. 8), broken line: fit to the saturated solution data 
(Eq. 9), dotted line: calculated equilibrium between pure solid TETA·2HCl and its saturated solution (Eq. 13), which becomes 
stable at the quadruple point (328 K, 6692 Pa, indicated by a solid square). At room temperature (≅ 300 K) going up in 
partial water vapor pressure first TETA·2HCl (s) is stable, after crossing the solid line TETA·2HCl·2H2O (s) is stable, and 
crossing the broken line the (saturated) solution becomes stable. Above 328 K, at low water vapor pressure TETA·2HCl (s) is 
stable and passing the dotted line, the solution becomes stable. 
3.6 The solubility of the different TETA⋅2HCl solid forms as a function of 
temperature 
By increasing the temperature for a mixture of TETA⋅2HCl with water for a fixed partial water 
vapor pressure (e.g. 2000 Pa), the solid line in Figure 8 will be crossed towards the right-hand side, 
implying that pure solid TETA⋅2HCl becomes stable in the presence of water vapor. This is illustrated 
by X-ray diffraction measurements on the dihydrate while increasing the temperature (see the 
Supporting Information Figure S3 for the diffraction patterns). In Figure 9, the intensity ratio of the 
dihydrate has been plotted against the form that appears upon dehydration, which is form I. It can be 
seen that for about four hours the hydrate remained stable. This was the time taken to heat up the 
sample from 293 K to 323 K. At 323 K dehydration started and it took another 4 to 5 hours to obtain 
pure form I. The amount of dihydrate that disappears is directly proportional to the amount of form I 
appearing. The dehydration is therefore displacive and this is a clear indication that the structures of 
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the dihydrate and form I are related. In addition, thermogravimetric measurements on the dihydrate 
demonstrate the loss of water and the subsequent melting of form I without any significant thermal 
event in between (see Supporting Information Figure S4), again indicative of a displacive transition of 
the dihydrate into form I.33 Such dehydration behavior has also been observed previously for 
potassium guaiacol sulfonate, even though its temperature of dehydration was much higher due to 
the presence of potassium.34 
 
Figure 9. Normalized X-ray intensity (of all peaks together) for the dihydrate (open circles) at 323 K (first four hours heating 
from 298 – 323 K) as a function of time. While the dihydrate disappears form I (solid circles) appears and the crossover of 
the intensities occurs at 50%. This indicates that the transition is displacive as seen before for potassium guaiacol 
sulfonate.34 
As it is form I that is in equilibrium with the dihydrate, this information can be used to construct 
the T-x phase diagram involving TETA⋅2HCl form I and water. 
DSC measurements have been carried out with different concentrations of water and TETA⋅2HCl; 
the curves have been presented in Figure S5 in the Supporting Information. The concentrations and 
the observed transition temperatures (eutectic, liquidus of the dihydrate, peritectic, and liquidus of 
form I) have been compiled in Table S1 (supporting information). The three data points on the 
dihydrate liquidus line obtained by DVS (see Table 3) have been used in the fit too. A description of 
the calculations to fit the phase diagram has been provided in the supporting materials. The excess 
parameters have been described by a Redlich-Kister equation and the dihydrate has been described 
by an expression proposed by Kuznetsov et al.35, 36 
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It can be observed in Figure 10 that the dihydrate forms a peritectic equilibrium with the liquid 
phase and form I at 328 K with a calculated mole fraction of 0.266 for the mole fraction of the liquid. 
The metastable extension of the dihydrate liquidus line reaches its highest point at its melting 
temperature (obtained by the fit: 330 K). It can be seen that the liquidus values obtained by DVS 
(mole fractions of saturated solution indicated by triangles) coincide very well with the data obtained 
by DSC. This demonstrates that the solid-liquid transitions observed in the DSC pans clearly occur in 
the presence of water vapor and that the actual equilibrium involves a solid, a liquid and a vapor 
phase. 
Below the eutectic temperature (254.7 K i.e. about 18 degrees below the melting point of pure 
water) the liquidus lines become metastable and the two stable phases are ice and dihydrate (solids) 
at the left-hand side of the diagram. The eutectic concentration, 0.071 mole fraction, has been 
obtained by the fit. TETA⋅2HCl is in terms of weight fraction extremely soluble in water. However, the 
formation of the dihydrate reduces the solubility roughly twofold. This can be judged from the 
extrapolation of the liquidus line of form I from the peritectic temperature (the extension is a dashed 
line). 
 
Figure 10. The solubilities of the different forms of TETA⋅2HCl in water (temperature – composition phase diagram). The 
solid lines are the stable phase transitions and the metastable extensions are indicated by dashed lines. The diagram has 
been obtained by measurement and fitted using a Redlich-Kister expression for the excess functions. Details of the 
calculations can be found in the Supporting Information. The coordinates of the eutectic point of water and the dihydrate 
are 0.071 mole fraction and 254.7 K and the temperature for the peritectic equilibrium is 328.1 K with the saturated 
solution possessing a concentration of 0.266 mole fraction. The metastable melting point of the dihydrate according to the 
fit is 330 K. Data points for the liquidus of form I: open squares, data points for the liquidus of the dihydrate: open circles, 
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data points obtained by DVS: triangles, observed eutectic and peritectic transitions: crosses. Dashed line: estimated 
solubility of form II (metastable liquidus) using the excess quantities of the liquid and the melting data of form II 
(Supporting Information). 
Form II represents a different phase of form of TETA⋅2HCl. This implies that the liquid phase 
should exhibit the same excess behavior, whereas the difference in Gibbs energy by the solid form II 
is accounted for by its melting point and melting enthalpy. Because, form II is overall monotropic in 
relation to form I, its liquidus line will be located below the liquidus line for form I for the entire 
concentration range of the phase diagram. Its solubility will be consistently higher than that of form I. 
Measurements in the DVS demonstrated that the adsorption of water by form II was irregular 
(not shown), which can probably be interpreted as a transformation of form II into form I or into the 
dihydrate while dissolving in the presence of water vapor. This is most likely due to increased 
mobility of the molecules in the presence of water in combination with the fact that either form I or 
the dihydrate is the stable form instead of form II. 
3.7 The Pwater(T) curves and their relation to the T-x phase diagram 
Using information from the T-x phase diagram and the data obtained from the DVS, the 
relationships of the stabilities of the different condensed phases of TETA⋅2HCl with the partial water 
vapor pressure and with the temperature can be determined i.e. the lines in Figure 8 can be defined. 
The equilibrium represented by the solid line in Figure 8 can be represented in the following way: 
 
Eq. 7 
The water vapor provided in the DVS experiment, once at the appropriate vapor pressure, will form 
together with TETA⋅2HCl the dihydrate. At the side of the dihydrate in Eq. 8 water vapor is present 
too, even if it doesn’t appear in the equation, otherwise the dihydrate would not be stable. The 
equilibrium Eq. 7 also occurs in the lower right-hand side of the T-x phase diagram, where both 
TETA⋅2HCl (s) and TETA⋅2HCl⋅2H2O (s) exist in the presence, necessarily, of water vapor, even if it is 
not indicated (or presumed negligible) in the T-x representation. 
The dashed line in Figure 8 represents the equilibrium: 
  
Eq. 8 
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The dihydrate dissolves into liquid water that is provided as water vapor and a single liquid phase 
forms that consists of dissolved TETA⋅2HCl and water. The equilibrium contains x H2O (g) molecules, 
because the concentration of the saturated solution depends on the temperature. The actual 
concentrations have been reported in Table 3. The same equilibrium can be found in the T-x phase 
diagram as the liquidus of the dihydrate as this liquidus will only exist in the presence of the water 
vapor. 
The last equilibrium in Figure 8 is the dotted line, which has not been observed experimentally in 
the DVS, but which must exist, as it is the direct solubilization of TETA⋅2HCl in water without passing 
through the hydrate: 
  
Eq. 9 
It is also present in the T-x diagram as the liquidus of form I. Clearly, the latter equilibrium only 
becomes stable, once the dihydrate ceases to be stable. The exchange occurs at the “quadruple 
point” in Figure 8, where considering the intersecting equilibria, water vapor, solid TETA⋅2HCl (form 
I), solid TETA⋅2HCl⋅2H2O and the liquid mixture are in equilibrium. This quadruple point or invariant 
can be found back in the T-x diagram of Figure 10 as the peritectic equilibrium between the pure 
solid, the liquid and the dihydrate under the implied presence of the water vapor. Therefore, the 
crossing of the lines in Figure 7 must occur at 328 K, the peritectic temperature. Another example for 
which it has been clearly illustrated that the peritectic transition is a quadruple point is citric acid.32 
The Clausius-Clapeyron equation describes the pressure of a condensed phase as a function of 
temperature: 
         
Eq. 10 
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With P the vapor pressure, α a condensed phase, ΔαvapH the enthalpy of vaporization, R the gas 
constant 8.3145 J K-1mol-1, T the temperature and Bαvap an integration constant for the condensed 
phase α. The Clausius-Clapeyron equation is in fact the result of the integration of the Clapeyron 
equation for a condensed phase – vapor system in which the volume of the condensed phase has 
been neglected. 
In Table 3, the water vapor pressures of two condensed phases, the dihydrate and the saturated 
solution, have been provided as a function of temperature. Fitting both by plotting ln(P) against 1/T 
taking into account the fact that both lines need to cross at 328 K leads to the two following 
expressions: 
Dihydrate:  
Eq. 11 
Saturated solution:   
Eq. 12 
The enthalpies are given in J mol-1 of water and the water vapor pressures in Pa because it is the 
water that moves between the condensed phase and the vapor phase (the vapor pressure of the salt 
TETA⋅2HCl is considered to be negligible).  
The water vapor pressure as a function of temperature for the equilibrium between form I and 
the liquid (Eq. 9) can be calculated with the temperature of the peritectic equilibrium Tquadruple and 
Pwater , quadruple which can be obtained through Eq. 11 or Eq. 12. The only unknown is the enthalpy of 
vaporization when water in the saturated solution vaporizes to form pure solid TETA⋅2HCl. However, 
the enthalpy is a function of state and thus cycling around the quadruple point (Figure 8) starting at 
pure TETA⋅2HCl (s) in the presence of water vapor, passing the dihydrate and the saturated solution 
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and returning through the last equilibrium back to the pure solid, the enthalpy difference must be 
equal to zero. The enthalpy is calculated in the supporting information. The resulting equation for the 
vapor pressure of the saturated solution against the pure solid is: 
 Form I saturated solution:  
Eq. 13 
The line representing this expression runs in between the two other lines in Figure 8 and it is the 
stable equilibrium above the quadruple point 328 K and 6692 Pa. It is the partial water vapor 
pressure belonging to the liquidus line of Eq. 9, the equilibrium between form I and the liquid phase. 
4 Conclusions 
The present paper establishes the interplay between the variables temperature and humidity 
and the solid phases of triethylenetetramine dihydrochloride. At room temperature, Form I is the 
stable phase under low relative humidity values and the single stable phase for the pure API, but 
once above 40 % RH at 20 °C, the dihydrate of TETA⋅2HCl becomes the stable solid. If the relative 
humidity rises above 70 %, the solid turns into a solution and no solid phase is stable anymore. This 
physical behavior has been linked directly to the chemical stability of the API; dihydrate degrades 
more quickly than form I, which is rather stable in the absence of humidity and oxygen, and in the 
solution the degradation of TETA⋅2HCl accelerates even more. 
The role of the water vapor pressure has been demonstrated by the dynamic vapor sorption 
experiments, but also by the fact that the data obtained by DSC for the water – API mixtures 
coincides with those obtained by DVS. The vapor phase cannot be ignored in the DSC measurements 
and must be part of the equilibria in the DVS as well as in the DSC capsules. 
X-ray diffraction measurements as a function of the temperature demonstrate the transition of 
the dihydrate into form I. This implies that there is an equilibrium between the two solids, which 
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translates into the peritectic transition in the T-x phase diagram. There is no direct connection 
between the less stable form II and the dihydrate. DVS measurements of form II do not lead to 
consistent results, which in turn implies that form II randomly turns into the different phases form I, 
the dihydrate, or the solution depending on the microstates and conditions in the sample. This 
random behavior is fully consistent with the lower stability of form II in relation to the other phases.  
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